1. Antibody-Based Targeting of Interferon-Beta-1a Mutein in HER2-Positive Cancer Enhances Antitumor Effects Through Immune Responses and Direct Cell Killing
   Chan Gyu Lee et al, 2021, Frontiers in Pharmacology CrossRef
2. Identification and overcoming rituximab resistance in diffuse large B-cell lymphoma using next-generation sequencing
   Min Ji Jeon et al, 2023, The Korean Journal of Internal Medicine CrossRef
3. Clinical relevance and therapeutic implications of CD20 expression in Hodgkin's lymphoma
   Marcelo Antônio Oliveira Santos Veloso et al, 2024, Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal CrossRef
4. Interferons α and β in cancer: therapeutic opportunities from new insights
   Ernest C. Borden, 2019, Nature Reviews Drug Discovery CrossRef
5. 89Zr-ImmunoPET Shows Therapeutic Efficacy of Anti-CD20-IFNα Fusion Protein in a Murine B-cell Lymphoma Model
   Kirstin A. Zettlitz et al, 2022, Molecular Cancer Therapeutics CrossRef
6. Interferon-alpha-based immunotherapies in the treatment of B cell-derived hematologic neoplasms in today’s treat-to-target era
   Li Zhang et al, 2017, Experimental Hematology & Oncology CrossRef
7. Mechanism and Treatment of Rituximab Resistance in Diffuse Large Bcell Lymphoma
   Linqing Zou et al, 2019, Current Cancer Drug Targets CrossRef
8. Sulforaphane induces differential modulation of mitochondrial biogenesis and dynamics in normal cells and tumor cells
   Mario Negrette-Guzmán et al, 2017, Food and Chemical Toxicology CrossRef
9. Discovering the Potent Inhibitors Against Babesia bovis in vitro and Babesia microti in vivo by Repurposing the Natural Product Compounds
   Yongchang Li et al, 2021, Frontiers in Veterinary Science CrossRef
10. Resistance to anticancer immunity in cancer patients: potential strategies to reverse resistance
    B. Bonavida et al, 2017, Annals of Oncology CrossRef
11. Prognostic stratification improvement by integrating ID1/ID3/IGJ gene expression signature and immunophenotypic profile in adult patients with B-ALL
    Nataly Cruz-Rodriguez et al, 2017, Journal of Experimental & Clinical Cancer Research CrossRef
12. Modeling and affinity maturation of an anti-CD20 nanobody: a comprehensive in-silico investigation
    Alireza Poustforoosh et al, 2023, Scientific Reports CrossRef
13. Drug Resistance in Rheumatological Diseases
    Hassan Waqar et al, 2021, Biochemistry of Drug Resistance CrossRef
14. ZLD1122, a novel EZH2 and EZH1 small molecular inhibitor, blocks H3K27 methylation and diffuse large B cell lymphoma cell growth
    Tiantao Gao et al, 2016, RSC Advances CrossRef
15. Converting Lymphoma Cells into Potent Antigen-Presenting Cells for Interferon-Induced Tumor Regression
    Jing Liao et al, 2017, Cancer Immunology Research CrossRef